139 related articles for article (PubMed ID: 30474593)
1. Corticosteroid therapy alone for the treatment of C3 glomerulonephritis in association with monoclonal gammopathy
.
Sathick IJ; Zand L; Nasr SH; Leung N
Clin Nephrol; 2019 Feb; 91(2):79-86. PubMed ID: 30474593
[TBL] [Abstract][Full Text] [Related]
2. Clinical findings, pathology, and outcomes of C3GN after kidney transplantation.
Zand L; Lorenz EC; Cosio FG; Fervenza FC; Nasr SH; Gandhi MJ; Smith RJ; Sethi S
J Am Soc Nephrol; 2014 May; 25(5):1110-7. PubMed ID: 24357668
[TBL] [Abstract][Full Text] [Related]
3. A Case of Switch from C3 Glomerulonephritis to Proliferative Glomerulonephritis with Monoclonal IgG Deposits.
Zhang F; Gao E; Liang S; Yang N; Wang J
Ann Clin Lab Sci; 2018 Jul; 48(4):528-533. PubMed ID: 30143498
[TBL] [Abstract][Full Text] [Related]
4. C3 glomerulonephritis associated with monoclonal gammopathy: a case series.
Zand L; Kattah A; Fervenza FC; Smith RJ; Nasr SH; Zhang Y; Vrana JA; Leung N; Cornell LD; Sethi S
Am J Kidney Dis; 2013 Sep; 62(3):506-14. PubMed ID: 23623956
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal immunoglobulin mediates complement activation in monoclonal gammopathy associated-C3 glomerulonephritis.
Li LL; Li ZY; Wang SX; Yu XJ; Tan Y; Wang Y; Yu F; Zhao MH
BMC Nephrol; 2019 Dec; 20(1):459. PubMed ID: 31823738
[TBL] [Abstract][Full Text] [Related]
6. C3 glomerulonephritis associated with monoclonal gammopathy: a retrospective case series study from a single institute in China.
Zhang X; Yu XJ; Li DY; Wang SX; Zhou FD; Zhao MH
Ren Fail; 2021 Dec; 43(1):1437-1445. PubMed ID: 34658305
[TBL] [Abstract][Full Text] [Related]
7. A 78-Year-Old Man with Chronic Kidney Disease and Monoclonal Gammopathy Who Developed Post-Transplant C3 Glomerulopathy - Recurrence or De Novo? A Case Report and Literature Review.
Ruiz-Fuentes MC; Caba-Molina M; Polo-Moyano A; Palomares-Bayo M; Galindo-Sacristan P; De Gracia-Guindo C
Am J Case Rep; 2023 Jun; 24():e939726. PubMed ID: 37329130
[TBL] [Abstract][Full Text] [Related]
8. C3 glomerulonephritis and autoimmune disease: more than a fortuitous association?
Alexander MP; Fervenza FC; De Vriese AS; Smith RJH; Nasr SH; Cornell LD; Herrera Hernandez LP; Zhang Y; Sethi S
J Nephrol; 2016 Apr; 29(2):203-209. PubMed ID: 26187133
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Monoclonal Gammopathy-associated C3 Glomerulopathy With Daratumumab-based Therapy.
Coltoff A; Bomback A; Shirazian S; Lentzsch S; Bhutani D
Clin Lymphoma Myeloma Leuk; 2021 Aug; 21(8):e674-e677. PubMed ID: 34023209
[No Abstract] [Full Text] [Related]
10. Glomerulonephritis with isolated C3 deposits and monoclonal gammopathy: a fortuitous association?
Bridoux F; Desport E; Frémeaux-Bacchi V; Chong CF; Gombert JM; Lacombe C; Quellard N; Touchard G
Clin J Am Soc Nephrol; 2011 Sep; 6(9):2165-74. PubMed ID: 21784830
[TBL] [Abstract][Full Text] [Related]
11. C3 glomerulonephritis with a severe crescentic phenotype.
Ravindran A; Fervenza FC; Smith RJH; Sethi S
Pediatr Nephrol; 2017 Sep; 32(9):1625-1633. PubMed ID: 28593446
[TBL] [Abstract][Full Text] [Related]
12. Favorable effect of bortezomib in dense deposit disease associated with monoclonal gammopathy: a case report.
Hirashio S; Satoh A; Arima T; Mandai K; Awaya T; Oshima K; Hara S; Masaki T
BMC Nephrol; 2018 May; 19(1):108. PubMed ID: 29724182
[TBL] [Abstract][Full Text] [Related]
13. High-dose melphalan and autologous hematopoietic stem cell transplant in patient with C3 glomerulonephritis associated with monoclonal gammopathy
.
Lepori N; Cheungpasitporn W; Sethi S; Murray D; Kumar S; Leung N; Giridhar KV; Fervenza FC
Clin Nephrol; 2018 Apr; 89(4):291-299. PubMed ID: 29249234
[TBL] [Abstract][Full Text] [Related]
14. Safety and Efficacy of Daratumumab in Patients with Proliferative GN with Monoclonal Immunoglobulin Deposits.
Zand L; Rajkumar SV; Leung N; Sethi S; El Ters M; Fervenza FC
J Am Soc Nephrol; 2021 May; 32(5):1163-1173. PubMed ID: 33685975
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal gammopathy-associated proliferative glomerulonephritis.
Sethi S; Rajkumar SV
Mayo Clin Proc; 2013 Nov; 88(11):1284-93. PubMed ID: 24182705
[TBL] [Abstract][Full Text] [Related]
16. Membranoproliferative glomerulonephritis and C3 glomerulonephritis: frequency, clinical features, and outcome in children.
Okuda Y; Ishikura K; Hamada R; Harada R; Sakai T; Hamasaki Y; Hataya H; Fukuzawa R; Ogata K; Honda M
Nephrology (Carlton); 2015 Apr; 20(4):286-92. PubMed ID: 25524631
[TBL] [Abstract][Full Text] [Related]
17. C3 glomerulonephritis associated with monoclonal gammopathy of renal significance: case report.
Alonso-Titos J; Perea-Ortega L; Sola E; Torres-Rueda A; León M; Toledo R; Duarte AD; Vazquez T; Martinez-Esteban MD; Bailen A; Ruiz-Esteban P; Hernandez D
BMC Nephrol; 2018 Jun; 19(1):129. PubMed ID: 29884135
[TBL] [Abstract][Full Text] [Related]
18. Clinico-pathologic spectrum of C3 glomerulopathy-an Indian experience.
Viswanathan GK; Nada R; Kumar A; Ramachandran R; Rayat CS; Jha V; Sakhuja V; Joshi K
Diagn Pathol; 2015 Mar; 10():6. PubMed ID: 25889427
[TBL] [Abstract][Full Text] [Related]
19. C3 Glomerulopathy With Concurrent Thrombotic Microangiopathy: Clinical and Immunological Features.
Chabannes M; Rabant M; El Sissy C; Dragon-Durey MA; Vieira Martins P; Meuleman MS; Karras A; Buob D; Bridoux F; Daugas E; Audard V; Caillard S; Olagne J; Kandel C; Ferlicot S; Philipponnet C; Crepin T; Thervet E; Ducloux D; Frémeaux-Bacchi V; Chauvet S
Am J Kidney Dis; 2023 Sep; 82(3):279-289. PubMed ID: 37061020
[TBL] [Abstract][Full Text] [Related]
20. Kidney diseases associated with monoclonal immunoglobulin M-secreting B-cell lymphoproliferative disorders: a case series of 35 patients.
Chauvet S; Bridoux F; Ecotière L; Javaugue V; Sirac C; Arnulf B; Thierry A; Quellard N; Milin S; Bender S; Goujon JM; Jaccard A; Fermand JP; Touchard G
Am J Kidney Dis; 2015 Nov; 66(5):756-67. PubMed ID: 25987261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]